Novo Nordisk Price War: -2.6% Stock Pressure After CagriSema Shock
Novo Nordisk price war, CagriSema shock, and stock plunge: How hard does the GLP-1 double blow hit the market leader and what does it mean...
Intel Forecast +5.7%: Can the AI Rally Hold Up to $55?
Intel forecast after +5.7% rally: How sustainable is the support and how realistic is a comeback toward $55?
NVIDIA Quarter in AI Stress Test: 68% Revenue Surge and Margin Boom
NVIDIA quarter ahead of earnings: Wall Street expects around 68% revenue growth, strong margins, and clarity on AI demand and China risks.
E.ON Investment Program Exceeds €48B: Opportunity for Investors?
E.ON's investment program rises to €48B, profits and dividends grow – what does this mean for investors and the stock price?
Lucid Quarter: Revenue Jump of 123% Faces Loss Surge
Lucid quarter with revenue up 123%, but billions in losses – will liquidity last until 2027 and how realistic are the production goals?
Diageo Dividend Cut -5.9%: Halved Payout After Weak First Half
Diageo dividend cut, stock -5.9%: What does the halved payout and new dividend policy mean for valuation and investors?